Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE-listed rideshare and delivery platform (UBER) with $43.6B gross bookings in 2023 and first GAAP profit; expanding with Waymo AV partnership competing with Lyft and DoorDash across mobility verticals.
Uber is a global technology platform that revolutionized urban transportation — connecting riders with drivers through a smartphone app for on-demand rides (UberX, UberXL, UberBlack) and expanding into food delivery (Uber Eats), freight logistics (Uber Freight), grocery delivery, and package delivery. Listed on NYSE (NYSE: UBER), Uber operates in 70+ countries and 10,000+ cities, generating $43.6 billion in gross bookings and $10.1 billion in revenue in 2023, achieving its first full-year GAAP profitability in 2023 after years of losses.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.